High-dose chemotherapy of metastatic breast cancer: the end of the beginning?

por Crown, J.
Publicado 1997

Overcoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancer

por Mohd Sharial, M. S. N., Crown, J., Hennessy, B. T.
Publicado 2012

Melanoma-associated antigen family protein-D4: clinical significance and functional relevance in breast cancer

por Germano, S, Rani, S, Kennedy, S, Crown, J, Clynes, M, O'Driscoll, L
Publicado 2010

SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue

por Kennedy, S, Clynes, M, Doolan, P, Mehta, J P, Rani, S, Crown, J, O'Driscoll, L
Publicado 2008

Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma

por MAHGOUB, T., EUSTACE, A.J., COLLINS, D.M., WALSH, N., O'DONOVAN, N., CROWN, J.
Publicado 2015

Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer

por Malinovszky, K M, Gould, A, Foster, E, Cameron, D, Humphreys, A, Crown, J, Leonard, R C F
Publicado 2006

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer

por Ryan, B, O'Donovan, N, Browne, B, O'Shea, C, Crown, J, Hill, A D K, McDermott, E, O'Higgins, N, Duffy, M J
Publicado 2005

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells

por Caiazza, F, McGowan, P M, Mullooly, M, Murray, A, Synnott, N, O'Donovan, N, Flanagan, L, Tape, C J, Murphy, G, Crown, J, Duffy, M J
Publicado 2015

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis

por Walsh, N, Kennedy, S, Larkin, A M, Tryfonopoulos, D, Eustace, A J, Mahgoub, T, Conway, C, Oglesby, I, Collins, D, Ballot, J, Ooi, W S, Gullo, G, Clynes, M, Crown, J, O'Driscoll, L
Publicado 2010

Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?

por Cameron, D A, Anderson, A, Toy, E, Evans, T R J, Le Vay, J H, Kennedy, I C S, Grieve, R J, Perren, T J, Jones, A, Mansi, J, Crown, J, Leonard, R C F
Publicado 2002

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

por McKiernan, E, O'Brien, K, Grebenchtchikov, N, Geurts-Moespot, A, Sieuwerts, A M, Martens, J W M, Magdolen, V, Evoy, D, McDermott, E, Crown, J, Sweep, F C G J, Duffy, M J
Publicado 2008

The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer

por Eustace, A. J., Madden, S. F., Fay, J., Collins, D. M., Kay, E. W., Sheehan, K. M., Furney, S., Moran, B., Fagan, A., Morris, P. G., Teiserskiene, A., Hill, A. D., Grogan, L., Walshe, J. M., Breathnach, O., Power, C., Duke, D., Egan, K., Gallagher, W. M., O’Donovan, N., Crown, J., Toomey, S., Hennessy, B. T.
Publicado 2021